User menu

Impact of being overweight on factor VIII dosing in children with haemophilia A.

Bibliographic reference Henrard, Séverine ; Hermans, Cédric. Impact of being overweight on factor VIII dosing in children with haemophilia A.. In: Haemophilia, Vol. 22, no. 3, p. 361-367 (2016)
Permanent URL
  1. Bolton-Maggs Paula HB, Pasi K John, Haemophilias A and B, 10.1016/s0140-6736(03)13405-8
  2. Ingram G. I. C., CALCULATING THE DOSE OF FACTOR VIII IN THE MANAGEMENT OF HAEMOPHILIA, 10.1111/j.1365-2141.1981.tb02722.x
  3. Bj??rkman Sven, Berntorp Erik, Pharmacokinetics of Coagulation Factors : Clinical Relevance for Patients with Haemophilia, 10.2165/00003088-200140110-00003
  4. HENRARD S., SPEYBROECK N., HERMANS C., Body weight and fat mass index as strong predictors of factor VIII in vivo recovery in adults with hemophilia A : BW and FMI as predictors of FVIII recovery, 10.1111/j.1538-7836.2011.04431.x
  5. Henrard S., Speybroeck N., Hermans C., Impact of being underweight or overweight on factor VIII dosing in hemophilia A patients, 10.3324/haematol.2013.084038
  6. Kepa S., Horvath B., Reitter-Pfoertner S., Schemper M., Quehenberger P., Grundbichler M., Heistinger M., Neumeister P., Mannhalter C., Pabinger I., Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A, 10.1111/hae.12592
  7. Aronstam A, McLellan D S, Wassef M, Mbatha P S, Effect of height and weight on the in vivo recovery of transfused factor VIII C., 10.1136/jcp.35.3.289
  8. BJÖRKMAN S., BLANCHETTE V. S., FISCHER K., OH M., SPOTTS G., SCHROTH P., FRITSCH S., PATRONE L., EWENSTEIN B. M., COLLINS P. W., , Comparative pharmacokinetics of plasma- and albumin-free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age-related differences and implications for dose tailoring, 10.1111/j.1538-7836.2010.03757.x
  9. BLANCHETTE V. S., SHAPIRO A. D., LIESNER R. J., HERNNDEZ NAVARRO F., WARRIER I., SCHROTH P. C., SPOTTS G., EWENSTEIN B. M., , Plasma and albumin-free recombinant factorVIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients, 10.1111/j.1538-7836.2008.03032.x
  10. Cole T. J., Green P. J., Smoothing reference centile curves: The lms method and penalized likelihood, 10.1002/sim.4780111005
  11. WHO Child Growth Standards based on length/height, Acta Paediatr Suppl, 450, 76 (2006)
  12. Henrard S., Speybroeck N., Hermans C., Classification and regression tree analysis vs. multivariable linear and logistic regression methods as statistical tools for studying haemophilia, 10.1111/hae.12778
  13. Marshall Roger J., The use of classification and regression trees in clinical epidemiology, 10.1016/s0895-4356(00)00344-9
  14. The R Core Team, R: A Language and Environment for Statistical Computing (2012)
  15. COLLINS P. W., FISCHER K., MORFINI M., BLANCHETTE V. S., BJÖRKMAN S., , Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia : PHARMACOKINETICS AND PROPHYLAXIS, 10.1111/j.1365-2516.2010.02370.x
  16. Wong Trisha E., Majumdar Suvankar, Adams Elizabeth, Bergman Sarah, Damiano Mary Lou, Deutsche Joann, Recht Michael, Overweight and Obesity in Hemophilia, 10.1016/j.amepre.2011.09.008
  17. COLLINS P. W., BLANCHETTE V. S., FISCHER K., BJÖRKMAN S., OH M., FRITSCH S., SCHROTH P., SPOTTS G., ASTERMARK J., EWENSTEIN B., , Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A, 10.1111/j.1538-7836.2008.03270.x
  18. Gringeri A., Wolfsegger M., Steinitz K. N., Reininger A. J., Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis - new insight provided by pharmacokinetic modelling, 10.1111/hae.12605
  19. FISCHER K., COLLINS P., BJÖRKMAN S., BLANCHETTE V., OH M., FRITSCH S., SCHROTH P., SPOTTS G., EWENSTEIN B., Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials : BLEEDING PATTERNS ON PROPHYLAXIS, 10.1111/j.1365-2516.2010.02450.x
  20. Fischer Kathelijn, Pendu Ronan, van Schooten Carina J., van Dijk Karin, Denis Cécile V., van den Berg H. Marijke, Lenting Peter J., Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients, 10.1371/journal.pone.0006745
  21. Knobe Karin, Berntorp Erik, New treatments in hemophilia: insights for the clinician, 10.1177/2040620712440007